Home Cart Sign in  
Chemical Structure| 53251-94-8 Chemical Structure| 53251-94-8

Structure of Pinaverium bromide
CAS No.: 53251-94-8

Chemical Structure| 53251-94-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pinaverium bromide acts as a calcium channel blocker in helping to restore the normal contraction process of the bowel.

Synonyms: Icosapentaenoic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pinaverium bromide

CAS No. :53251-94-8
Formula : C26H41Br2NO4
M.W : 591.42
SMILES Code : CC1(C)C2CCC(CCOCC[N+]3(CC4=CC(OC)=C(OC)C=C4Br)CCOCC3)C1C2.[Br-]
Synonyms :
Icosapentaenoic acid
MDL No. :MFCD01713435
InChI Key :IKGXLCMLVINENI-UHFFFAOYSA-M
Pubchem ID :40703

Safety of Pinaverium bromide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01641224 Irritable Bowel Syndrome Not Applicable Unknown May 2014 China, Jiangsu ... More >> Second Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine Nanjing, Jiangsu, China, 210017 Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine Nanjing, Jiangsu, China, 210029 China Beijing Xuanwu Hospital of Traditional Chinese Medicine affiliated to Capital Medical University. Beijing, China, 100050 Shanghai First People's Hospital affiliated to Shanghai Tiao Tong University Shanghai, China, 200240 Less <<
NCT02330029 Irritable Bowel Syndrome Not Applicable Unknown May 2017 China, Jiangsu ... More >> Second Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine Nanjing, Jiangsu, China, 210017 Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine Nanjing, Jiangsu, China, 210029 China Beijing Xuanwu Hospital of Traditional Chinese Medicine affiliated to Capital Medical University. Beijing, China, 100050 Shanghai First People's Hospital affiliated to Shanghai Tiao Tong University Shanghai, China, 200240 Less <<
NCT01678781 - Completed - China ... More >> Site reference ID/Investigator# 94519 Beijing, China, 100034 Site reference ID/Investigator# 95475 Guangzhou City, China, 510515 Site reference ID/Investigator# 94521 Guangzhou, China, 510080 Site reference ID/Investigator # 94518 Shanghai, China, 200127 Site reference ID/Investigator # 94517 Shanghai, China, 200433 Site reference ID/Investigator # 94516 Shanghai, China Site reference ID/Investigator # 94515 Wuhan, China, 430022 Egypt Site Reference ID/Investigator# 95908 Alexandria, Egypt Site reference ID/Investigator# 95900 Cairo, Egypt Site reference ID/Investigator# 95901 El Sharkya, Egypt Site reference ID/Investigator# 95902 Giza, Egypt Site reference ID/Investigator# 95903 Giza, Egypt Site Reference ID/Investigator# 95906 Port Said, Egypt Mexico Site reference ID/Investigaot# 94525 Guadalajara, Mexico, 49000 Site refernce ID/Investigator# 94527 Mexico City, Mexico, 54055 Site reference ID/Investigator# 94523 Tampico, Mexico, 89190 Poland Site reference ID/Investigator# 85314 Bialystok, Poland, 15-270 Site Reference ID/Investigator# 85297 Bialystok, Poland, 15-351 Site Reference ID/Investigator# 85298 Bydgoszcz, Poland, 85-079 Site Reference ID/Investigator# 85293 Katowice, Poland, 40-031 Site Reference ID/Investigator# 85296 Lodz, Poland, 91-473 Site reference ID/Investigator# 85313 Olsztyn, Poland, 10-501 Site Reference ID/Investigator# 85295 Poznan, Poland, 60-193 Site Reference ID/Investigator# 85294 Poznan, Poland, 60-539 Less <<
NCT02173964 Cancer Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT02833103 Sphincter of Oddi Dysfunction Phase 4 Unknown February 2018 China, Shanghai ... More >> Zhang Yong Recruiting Shanghai, Shanghai, China, 200092 Contact: Yong Zhang, MD,PhD    +86 21 25078999-7905       Principal Investigator: Yong Zhang, MD,PhD          Principal Investigator: Houbao Liu, MD,PhD          Sub-Investigator: Tao Suo, MD,PhD          Principal Investigator: Jian Wang, MD,PhD          Sub-Investigator: Wei Chen, MD,PhD          Principal Investigator: Yajin Chen, MD,PhD          Sub-Investigator: Yunyao Xu, MD,PhD          Principal Investigator: Xiujun Cai, MD,PhD          Sub-Investigator: Xiao Liang, MD,PhD          Sub-Investigator: Lin Ji, MD,PhD          Principal Investigator: Jianying Lou, MD,PhD          Sub-Investigator: Ji Wang, MD,PhD          Principal Investigator: Xitai Sun, MD,PhD          Sub-Investigator: Xiaodong Shan, MD,PhD          Principal Investigator: Yu He, MD,PhD          Sub-Investigator: Dajiang Li, MD,PhD Less <<
NCT02882451 Bile Duct Diseases Not Applicable Recruiting October 2017 China ... More >> Changhai Hospital, Second Military Medical University Recruiting Shanghai, China, 200433 Contact: zhaoshen Li, MD    86-21-81873241    zhaoshenlismmu@gmail.com    Principal Investigator: zhaoshen Li, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.69mL

0.34mL

0.17mL

8.45mL

1.69mL

0.85mL

16.91mL

3.38mL

1.69mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories